CANbridge Pharmaceuticals CAN103 Investigational New Drug Application Accepted by China’s National Medical Products Administration
BEIJING & CAMBRIDGE, Mass.–(BUSINESS WIRE)–CANbridge Pharmaceuticals Inc., a leading China-based global rare disease-focused biopharmaceutical company…
CampDoc Launches Group Registration to Simplify Event Enrollment for Camps and Youth Programs